397 related articles for article (PubMed ID: 36185720)
1. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer - nationwide population-based study.
Haider MB; Al Sbihi A; Chaudhary AJ; Haider SM; Edhi AI
World J Hepatol; 2022 Sep; 14(9):1804-1816. PubMed ID: 36185720
[TBL] [Abstract][Full Text] [Related]
2. The Evolution of Iron-Related Comorbidities and Hospitalization in Patients with Hemochromatosis: An Analysis of the Nationwide Inpatient Sample.
Abou Yassine A; MacDougall K; Sasso R; Shammaa Y; Alsheikh M; Abureesh M; Dahabra L; Alshami M; Mulrooney S
Blood Sci; 2023 Apr; 5(2):131-135. PubMed ID: 37228771
[TBL] [Abstract][Full Text] [Related]
3. The association of nonalcoholic steatohepatitis and hepatocellular carcinoma.
Asfari MM; Talal Sarmini M; Alomari M; Lopez R; Dasarathy S; McCullough AJ
Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1566-1570. PubMed ID: 32073443
[TBL] [Abstract][Full Text] [Related]
4. Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease.
Tan YW; Wang JM; Zhou XB
World J Hepatol; 2023 Feb; 15(2):237-254. PubMed ID: 36926239
[TBL] [Abstract][Full Text] [Related]
5. Worse Outcomes Associated With Liver Transplants: An Increasing Trend.
Siddiqui NA; Ullah N; Shaikh JR; Bhandari S; Ullah U; Khan SF; Khan OQ; Mohammed Abdul MK
Cureus; 2021 Aug; 13(8):e17534. PubMed ID: 34646593
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology.
Doycheva I; Zhang T; Amjad W; Thuluvath PJ
J Clin Exp Hepatol; 2020; 10(4):296-303. PubMed ID: 32655232
[TBL] [Abstract][Full Text] [Related]
7. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
Hirode G; Saab S; Wong RJ
JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population-based study and review of literature.
Almomani A; Kumar P; Onwuzo S; Boustany A; Krishtopaytis E; Hitawala A; Alshaikh D; Albakri A; Hussein L; Hussein E; Asaad I
J Gastroenterol Hepatol; 2023 Feb; 38(2):269-273. PubMed ID: 36328950
[TBL] [Abstract][Full Text] [Related]
9. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018).
Gu W; Hortlik H; Erasmus HP; Schaaf L; Zeleke Y; Uschner FE; Ferstl P; Schulz M; Peiffer KH; Queck A; Sauerbruch T; Brol MJ; Rohde G; Sanchez C; Moreau R; Arroyo V; Zeuzem S; Welsch C; Trebicka J
Lancet Reg Health Eur; 2022 Jan; 12():100240. PubMed ID: 34901909
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis.
Albhaisi S; Sun J; Sanyal AJ
Front Oncol; 2023; 13():1198871. PubMed ID: 37675229
[TBL] [Abstract][Full Text] [Related]
11. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
[TBL] [Abstract][Full Text] [Related]
12. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
[TBL] [Abstract][Full Text] [Related]
13. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Outcomes of Hospitalizations Due to Hepatocellular Carcinoma.
Mullangi S; Keesari PR; Zaher A; Pulakurthi YS; Adusei Poku F; Rajeev A; Vidiyala PL; Guntupalli AL; Desai M; Ohemeng-Dapaah J; Asare Y; Patel AA; Lekkala M
Cureus; 2021 Dec; 13(12):e20089. PubMed ID: 35003948
[TBL] [Abstract][Full Text] [Related]
15. Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.
Benhammou JN; Leng M; Shah SC; Cholankeril G; Dong TS; Patel AA; Tong MJ
JAMA Netw Open; 2023 Dec; 6(12):e2346380. PubMed ID: 38048128
[TBL] [Abstract][Full Text] [Related]
16. Hepatic iron overload and hepatocellular carcinoma.
Kew MC
Liver Cancer; 2014 Mar; 3(1):31-40. PubMed ID: 24804175
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
18. Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians.
Powell EE; Skoien R; Rahman T; Clark PJ; O'Beirne J; Hartel G; Stuart KA; McPhail SM; Gupta R; Boyd P; Valery PC
EClinicalMedicine; 2019; 11():44-53. PubMed ID: 31317132
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Cirrhosis on Outcomes of Patients Admitted With Diabetic Ketoacidosis: A Nationwide Study.
Mansour MM; Obeidat AE; Darweesh M; Mahfouz R; Kuwada S; Pyrsopoulos NT
Cureus; 2022 Jun; 14(6):e25870. PubMed ID: 35836436
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data.
Lee DU; Fan GH; Hastie DJ; Prakasam VN; Addonizio EA; Ahern RR; Seog KJ; Karagozian R
J Clin Exp Hepatol; 2021; 11(5):531-543. PubMed ID: 34511813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
